JAG2 and adenoma: The role of Notch1 in ovarian cancer was first studied by Hopfer et al., [87] who evaluated mRNA expression of Notch pathway members in ovarian adenocarcinomas, borderline tumors and adenomas and demonstrated more frequent expression of Jag2 and DLL1 in adenocarcinomas as compared to adenomas.